This is a cross-sectional analysis of data obtained from an ongoing, prospective, longitudinal study approved by the New York Eye and Ear Infirmary Institutional Review Board. Written, informed consent was obtained from all subjects, and the study adhered to the tenets of the Declaration of Helsinki.
We prospectively included patients with glaucoma or suspected glaucoma. All participants had open angles by gonioscopy, best corrected visual acuity of 20/40 or better, and refractive errors of +3.0 to −6.0 DS and less than 2.0 DC. Each participant had simultaneous color optic disc stereophotographs (Stereo Camera Model 3-DX; Nidek Inc., Palo Alto, CA), standard automated perimetry (Humphrey Visual Field Analyzer, 24-2 SITA-Standard strategy; Carl Zeiss Meditec, Inc., Dublin, CA), and FD-OCT (3D OCT-1000; Topcon Corporation, Tokyo, Japan) imaging of the optic nerve complex in both eyes on the same day. We excluded individuals with previous posterior segment intraocular surgery, secondary causes of glaucoma (uveitis, trauma, proliferative diabetic retinopathy, or retinal vascular obstruction), systemic or ocular diseases known to affect the visual field (pituitary lesions or demyelinating diseases), inability to perform visual field examinations reliably, and optic disc images of poor quality.
Glaucomatous optic disc damage was defined as neuroretinal rim thinning or notching, localized or diffuse retinal nerve fiber layer defect, or a between-eye asymmetry of the vertical cup-disc ratio >0.2. Standard automated perimetry results were considered abnormal if the pattern standard deviation was triggered at the 5%, 2%, 1%, or 0.5% levels or the glaucoma hemifield test result was outside normal limits. A perimetric abnormality required confirmation with an additional visual field test. Patients with suspected glaucoma had signs of glaucomatous optic disc damage with normal visual field test results. Those with established glaucoma had optic disc damage with repeatable visual field loss.
From this database (
n = 130), we further selected only patients with glaucoma or suspected glaucoma with clearly visible βPPA on good-quality optic disc photographs and high-quality FD-OCT scans (manufacturer-provided quality factor, ≥60.00). Stereophotographs were reviewed by two glaucoma specialists (SCP, CGVDM). We defined PPA as an inner crescent of chorioretinal atrophy with visible sclera and choroidal vessels (βPPA) and an outer irregular area of hypo- and hyperpigmentation (α-zone PPA).
8,9 The βPPA had to involve at least the temporal 180° of the optic disc and have a horizontal width of ≥150 μm in at least one meridian.